Image

A Study Comparing Anitocabtagene Autoleucel to Standard of Care Therapy in Participants With Relapsed/ Refractory Multiple Myeloma

Comparing new treatment to standard care for relapsed multiple myeloma.

Recruiting
18 years and older
All
Phase 3

This study is for people with a type of blood cancer called multiple myeloma (MM), which has returned after treatment or didn't respond to treatment. The study will compare a new drug, anitocabtagene autoleucel, to standard treatments. The main goal is to see which treatment helps people live longer without the cancer getting worse. People in the study will be followed up for 15 years to check long-term effects.

  • The study is open to those who've had 1-3 treatments before, including specific medicines like immunomodulatory drugs (IMiDs) and anti-CD38 antibodies.
  • Participants cannot join if they've had certain types of treatments before or have other serious health conditions.
  • The study requires regular visits and tests, and participants must be able to receive one of the standard treatment options.

Participants must have a good overall health status (ECOG performance status of 0 or 1), and women who can have children need a negative pregnancy test. This study may help improve future treatments for MM, but there are specific criteria to meet before joining.

Study details
    Multiple Myeloma

NCT06413498

Kite, A Gilead Company

8 March 2025

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

  Other languages supported:

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.